Skip to main content
. 2021 May;38(5):238–242. doi: 10.12788/fp.0111

TABLE 2.

Secondary End Points

Criteria Duloxetine Pregabalin Pregabalin + Duloxetine P value
(n = 77) (n = 77) (n = 20)
Weight change, % −0.3 1.5 +2.0 .18
Weight change after at least 12 months, lb −0.9 +3.6 +8.5 .05

Hemoglobin A1c change in and patients with prediabetes or diabetes mellitus, % (n = 43) (n = 50) (n = 12)
−0.1 +0.3 −0.3 .14

Weight change for patients prescribed duloxetine > 60 mg/d or pregabalin > 300 mg/d, lb (n = 13) (n = 21)
−2.8 +6.5 --- .05

Weight change for patients in Managing Overweight Veterans Everywhere program, lb (n = 10) (n = 8) (n = 5)
+1.5 +4.9 +3.4 .91